Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
Tulane Univ. New Orleans NICHD CRS
797
mi
from 43215
New Orleans, LA
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
Tulane Univ. New Orleans NICHD CRS
797
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
WNE Maternal Pediatric Adolescent AIDS CRS
607
mi
from 43215
Worcester, MA
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
WNE Maternal Pediatric Adolescent AIDS CRS
607
mi
from 43215
Worcester, MA
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
UMDNJ - Robert Wood Johnson Med. School, Div. of Allergy, Immunology & Infectious Diseases
453
mi
from 43215
New Brunswick, NJ
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
UMDNJ - Robert Wood Johnson Med. School, Div. of Allergy, Immunology & Infectious Diseases
453
mi
from 43215
New Brunswick, NJ
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
Rutgers - New Jersey Medical School CRS
467
mi
from 43215
Newark, NJ
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
Rutgers - New Jersey Medical School CRS
467
mi
from 43215
Newark, NJ
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
Jacobi Med. Ctr. Bronx NICHD CRS
486
mi
from 43215
Bronx, NY
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
Jacobi Med. Ctr. Bronx NICHD CRS
486
mi
from 43215
Bronx, NY
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
Nyu Ny Nichd Crs
479
mi
from 43215
New York, NY
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
Nyu Ny Nichd Crs
479
mi
from 43215
New York, NY
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
Columbia IMPAACT CRS
481
mi
from 43215
New York, NY
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
Columbia IMPAACT CRS
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
Harlem Hosp. Ctr. NY NICHD CRS
481
mi
from 43215
New York, NY
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
Harlem Hosp. Ctr. NY NICHD CRS
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
SUNY Stony Brook NICHD CRS
549
mi
from 43215
Stony Brook, NY
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
SUNY Stony Brook NICHD CRS
549
mi
from 43215
Stony Brook, NY
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases
278
mi
from 43215
Chapel HIll, NC
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases
278
mi
from 43215
Chapel HIll, NC
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
Oregon Health & Science Univ. - Dept. of Peds., Div. of Infectious Disease
2027
mi
from 43215
Portland, OR
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
Oregon Health & Science Univ. - Dept. of Peds., Div. of Infectious Disease
2027
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
St. Jude/UTHSC CRS
507
mi
from 43215
Memphis, TN
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
St. Jude/UTHSC CRS
507
mi
from 43215
Memphis, TN
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
Texas Children's Hosp. CRS
995
mi
from 43215
Houston, TX
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hosp. CRS
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital CRS
2005
mi
from 43215
Seattle, WA
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital CRS
2005
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS
1797
mi
from 43215
San Juan,
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS
1797
mi
from 43215
San Juan,
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
Washington University Therapeutics (WT) CRS
394
mi
from 43215
Saint Louis, MO
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
Washington University Therapeutics (WT) CRS
394
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated:  12/31/1969
SUNY Upstate Med. Univ., Dept. of Peds.
414
mi
from 43215
Syracuse, NY
Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children
A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Age
Status: Enrolling
Updated: 12/31/1969
SUNY Upstate Med. Univ., Dept. of Peds.
414
mi
from 43215
Syracuse, NY
Click here to add this to my saved trials
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital Los Angeles
1973
mi
from 43215
Los Angeles, CA
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Los Angeles
1973
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth
Status: Enrolling
Updated:  12/31/1969
University of Southern California
1970
mi
from 43215
Los Angeles, CA
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth
Status: Enrolling
Updated: 12/31/1969
University of Southern California
1970
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth
Status: Enrolling
Updated:  12/31/1969
Children's Diagnostic and Teatment Center
972
mi
from 43215
Fort Lauderdale, FL
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth
Status: Enrolling
Updated: 12/31/1969
Children's Diagnostic and Teatment Center
972
mi
from 43215
Fort Lauderdale, FL
Click here to add this to my saved trials
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth
Status: Enrolling
Updated:  12/31/1969
University of Maryland
343
mi
from 43215
Baltimore, MD
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth
Status: Enrolling
Updated: 12/31/1969
University of Maryland
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Michigan
164
mi
from 43215
Detroit, MI
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Michigan
164
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth
Motivational Enhancement to Promote Health and Reduce Risk in HIV-Infected Youth
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3
Status: Enrolling
Updated:  12/31/1969
University of Southern California (1201)
1972
mi
from 43215
Los Angeles, CA
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3
Status: Enrolling
Updated: 12/31/1969
University of Southern California (1201)
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3
Status: Enrolling
Updated:  12/31/1969
University of California, San Diego, AVRC CRS (701)
1951
mi
from 43215
San Diego, CA
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3
Status: Enrolling
Updated: 12/31/1969
University of California, San Diego, AVRC CRS (701)
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3
Status: Enrolling
Updated:  12/31/1969
University of California San Francisco AIDS CRS (801)
2107
mi
from 43215
San Francisco, CA
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3
Status: Enrolling
Updated: 12/31/1969
University of California San Francisco AIDS CRS (801)
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3
Status: Enrolling
Updated:  12/31/1969
NY Univ. HIV/AIDS CRS (401)
477
mi
from 43215
New York, NY
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3
Status: Enrolling
Updated: 12/31/1969
NY Univ. HIV/AIDS CRS (401)
477
mi
from 43215
New York, NY
Click here to add this to my saved trials
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3
Status: Enrolling
Updated:  12/31/1969
Gaborone Prevention/Treatment Trials CRS (12701)
8262
mi
from 43215
Gaborone,
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis
A Strategy Study of Immediate Versus Deferred Initiation of Antiretroviral Therapy for AIDS Disease-Free Survival in HIV-Infected Persons Treated for Tuberculosis With CD4 Less Than 250 Cells/mm^3
Status: Enrolling
Updated: 12/31/1969
Gaborone Prevention/Treatment Trials CRS (12701)
8262
mi
from 43215
Gaborone,
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Usc Crs (1201)
1972
mi
from 43215
Los Angeles, CA
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Usc Crs (1201)
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
UCLA CARE Center CRS (601)
1972
mi
from 43215
Los Angeles, CA
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
UCLA CARE Center CRS (601)
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Stanford CRS (501)
2100
mi
from 43215
Palo Alto, CA
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Stanford CRS (501)
2100
mi
from 43215
Palo Alto, CA
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Ucsd, Avrc Crs (701)
1951
mi
from 43215
San Diego, CA
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Ucsd, Avrc Crs (701)
1951
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Ucsf Aids Crs (801)
2107
mi
from 43215
San Francisco, CA
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Ucsf Aids Crs (801)
2107
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
San Mateo County AIDS Program (505)
2101
mi
from 43215
Stanford, CA
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
San Mateo County AIDS Program (505)
2101
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Willow Clinic (507)
2101
mi
from 43215
Stanford, CA
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Willow Clinic (507)
2101
mi
from 43215
Stanford, CA
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Harbor-UCLA Med. Ctr. CRS (603)
1983
mi
from 43215
Torrance, CA
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Harbor-UCLA Med. Ctr. CRS (603)
1983
mi
from 43215
Torrance, CA
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital CRS (6101)
1153
mi
from 43215
Aurora, CO
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital CRS (6101)
1153
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Georgetown University CRS (GU CRS) (1008)
328
mi
from 43215
Washington,
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Georgetown University CRS (GU CRS) (1008)
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
University of Miami AIDS CRS (901)
996
mi
from 43215
Miami, FL
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
University of Miami AIDS CRS (901)
996
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Emory University
435
mi
from 43215
Atlanta, GA
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Emory University
435
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
The Ponce de Leon Ctr. CRS (5802)
436
mi
from 43215
Atlanta, GA
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
The Ponce de Leon Ctr. CRS (5802)
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Northwestern University CRS (2701)
274
mi
from 43215
Chicago, IL
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Northwestern University CRS (2701)
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Cook County Hospital Core Center (2705)
274
mi
from 43215
Chicago, IL
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Cook County Hospital Core Center (2705)
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Rush Univ. Med. Ctr. ACTG CRS (2702)
274
mi
from 43215
Chicago, IL
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Rush Univ. Med. Ctr. ACTG CRS (2702)
274
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Indiana University Hospital (2601)
166
mi
from 43215
Indianapolis, IN
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Indiana University Hospital (2601)
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Wishard Hospital (2603)
166
mi
from 43215
Indianapolis, IN
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Wishard Hospital (2603)
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Univ of Iowa Hosp and Clinic (1504)
459
mi
from 43215
Iowa City, IA
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Univ of Iowa Hosp and Clinic (1504)
459
mi
from 43215
Iowa City, IA
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
IHV Baltimore Treatment CRS (4651)
344
mi
from 43215
Baltimore, MD
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
IHV Baltimore Treatment CRS (4651)
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Adult AIDS CRS (201)
344
mi
from 43215
Baltimore, MD
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Adult AIDS CRS (201)
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital ACTG CRS (101)
643
mi
from 43215
Boston, MA
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
A Phase IIIB, Randomized Trial of Open-Label Efavirenz or Atazanavir With Ritonavir in Combination With Double-Blind Comparison of Emtricitabine/Tenofovir or Abacavir/Lamivudine in Antiretroviral-Naive Subjects
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital ACTG CRS (101)
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials